HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.990
-0.070 (-2.29%)
Oct 29, 2024, 4:00 PM EDT - Market closed
HeartSciences Income Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 | 0.06 |
| Revenue Growth (YoY) | 853.85% | 261.17% | -64.17% | -43.86% | -60.11% | - |
| Cost of Revenue | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.05 |
| Gross Profit | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.02 |
| Selling, General & Admin | 3.53 | 3.44 | 3.65 | 1.71 | 0.87 | 1.8 |
| Research & Development | 3.54 | 2.88 | 2.46 | 3 | 1.71 | 2.04 |
| Operating Expenses | 7.06 | 6.32 | 6.12 | 4.72 | 2.58 | 3.84 |
| Operating Income | -7.05 | -6.31 | -6.11 | -4.71 | -2.57 | -3.82 |
| Interest Expense | -0.34 | -0.35 | -0.24 | -0.37 | -0.13 | -0 |
| Other Non Operating Income (Expenses) | 0.1 | 0.05 | 0 | 0 | -0 | -0 |
| EBT Excluding Unusual Items | -7.29 | -6.61 | -6.35 | -5.08 | -2.7 | -3.82 |
| Gain (Loss) on Sale of Assets | - | - | - | - | 0 | -0.01 |
| Other Unusual Items | - | - | - | 0.25 | 0.25 | 0.02 |
| Pretax Income | -7.29 | -6.61 | -6.35 | -4.83 | -2.45 | -3.81 |
| Net Income | -7.29 | -6.61 | -6.35 | -4.83 | -2.45 | -3.81 |
| Net Income to Common | -7.29 | -6.61 | -6.35 | -4.83 | -2.45 | -3.81 |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 |
| Shares Change (YoY) | 471.27% | 343.39% | 139.56% | 0.15% | - | - |
| EPS (Basic) | -13.99 | -18.74 | -79.92 | -145.48 | -74.00 | -115.01 |
| EPS (Diluted) | -13.99 | -18.74 | -79.92 | -145.48 | -74.00 | -115.01 |
| Free Cash Flow | -6.75 | -6.13 | -5.79 | -3.65 | -2.45 | -3.85 |
| Free Cash Flow Per Share | -12.95 | -17.40 | -72.85 | -109.86 | -74.02 | -116.22 |
| Gross Margin | 67.31% | 67.31% | 45.71% | 45.11% | 58.35% | 27.61% |
| Operating Margin | -37907.43% | -33901.99% | -118698.33% | -32765.60% | -10030.18% | -5949.00% |
| Profit Margin | -39193.77% | -35511.87% | -123384.27% | -33592.57% | -9577.29% | -5937.99% |
| Free Cash Flow Margin | -36285.46% | -32981.94% | -112463.79% | -25367.54% | -9580.56% | -6000.78% |
| EBITDA | -7.02 | -6.28 | -6.09 | -4.68 | -2.53 | -3.77 |
| D&A For EBITDA | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 |
| EBIT | -7.05 | -6.31 | -6.11 | -4.71 | -2.57 | -3.82 |
Source: S&P Capital IQ. Standard template.
Financial Sources.